DrugPatentWatch Database Preview
Drugs in MeSH Category Nucleic Acid Synthesis Inhibitors
Email this page to a colleague
» See Plans and Pricing| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| West-ward Pharms Int | MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 064117-001 | Apr 19, 1995 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Antares Pharma Inc | OTREXUP PFS | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-009 | May 31, 2017 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Cumberland Pharms | REDITREX | methotrexate | SOLUTION;SUBCUTANEOUS | 210737-002 | Nov 27, 2019 | RX | No | No | Start Trial | Start Trial | Start Trial | ||||
| Xgen Pharms | DACTINOMYCIN | dactinomycin | INJECTABLE;INJECTION | 203999-001 | May 20, 2019 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
